| abstract |
The present invention relates to certain salts of (+)-or (-)-cisapride, more particularly (+)-or (-)-cisapride- (L) -tartrate, (+)-or (-)-cisapride Oral formulation of-(D) -tartrate, (+)-or (-)-cisapride-sulfate, or (+)-or (-)-cisapride-citrate, which is a drug-food interaction It avoids action and allows co-drug treatment of drugs that increase the pH of the stomach. The present invention relates in particular to solid oral dosage forms suitable for rapid dissolution. The invention also relates to tablets which can be prepared by compression directly. |